The Center for Bioelectronics develops benign or bioactive biomaterials such as allografts and scaffolds for cell, drug and controlled biotherapeutics delivery. We are developing innovative biomaterials, biosensor and bioelectronic devices that interact with biological systems to elicit the prescribed responses and biological integration as well as to serve as test beds to translate these technologies into clinical applications.

• Development of integration approaches to integrate devices based on cellular and biomolecular sensors, carbon nanotubes, and quantum dots with commercial integrated electronic circuit fabrication.
• Development of self-powered glucose biosensor for implantable glucose monitoring and targeted delivery of insulin.
• Fabrication of renewable biochemical in vivo energy harnessing technology based on blood metabolites to power small implantable devices.
• Design and development of flexible and wearable electronics for activity monitoring.
• Design and fabrication of multimodal sensors (Lactic acid, ROS, and glucose) to monitor the viability of vascular composite allograft for transplant applications.
• Design and fabrication of neural probes for electrical and chemical brain activity monitoring
• Design and synthesis of hydrogel and polymer for composite tissue engineering, biosensing and biotherapeutic delivery.